Emad Al Jaber, MD | |
2451 Fillingim St # 102, Mobile, AL 36617-2238 | |
(251) 470-5890 | |
(251) 471-7925 |
Full Name | Emad Al Jaber |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 19 Years |
Location | 2451 Fillingim St # 102, Mobile, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477920528 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | L4726SP (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fmc Jaguar | Mobile, AL | Dialysis facility |
Usa Health University Hospital | Mobile, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Usa Health Physician Billing Services Llc | 9931436912 | 266 |
News Archive
Adocia announces today positive final results for the first clinical trial on its innovative formulation combining insulin analog glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
African Americans with incomes below the poverty line have a significantly higher risk of chronic kidney disease than higher-income African-Americans or whites of any socioeconomic status, research led by scientists at Johns Hopkins and the National Institute on Aging shows. Conducted in a racially and socioeconomically diverse sample of participants from the city of Baltimore, Md., the study could help researchers eventually develop strategies to prevent CKD in vulnerable populations.
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc., today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.
› Verified 1 days ago
Entity Name | University Of South Alabama |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992746838 PECOS PAC ID: 3072425149 Enrollment ID: O20040115000773 |
News Archive
Adocia announces today positive final results for the first clinical trial on its innovative formulation combining insulin analog glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
African Americans with incomes below the poverty line have a significantly higher risk of chronic kidney disease than higher-income African-Americans or whites of any socioeconomic status, research led by scientists at Johns Hopkins and the National Institute on Aging shows. Conducted in a racially and socioeconomically diverse sample of participants from the city of Baltimore, Md., the study could help researchers eventually develop strategies to prevent CKD in vulnerable populations.
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc., today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.
› Verified 1 days ago
Entity Name | Usa Health Physician Billing Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720645468 PECOS PAC ID: 9931436912 Enrollment ID: O20190814000827 |
News Archive
Adocia announces today positive final results for the first clinical trial on its innovative formulation combining insulin analog glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
African Americans with incomes below the poverty line have a significantly higher risk of chronic kidney disease than higher-income African-Americans or whites of any socioeconomic status, research led by scientists at Johns Hopkins and the National Institute on Aging shows. Conducted in a racially and socioeconomically diverse sample of participants from the city of Baltimore, Md., the study could help researchers eventually develop strategies to prevent CKD in vulnerable populations.
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc., today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Emad Al Jaber, MD Po Box 40480, Mobile, AL 36640-0480 Ph: (251) 470-5890 | Emad Al Jaber, MD 2451 Fillingim St # 102, Mobile, AL 36617-2238 Ph: (251) 470-5890 |
News Archive
Adocia announces today positive final results for the first clinical trial on its innovative formulation combining insulin analog glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
African Americans with incomes below the poverty line have a significantly higher risk of chronic kidney disease than higher-income African-Americans or whites of any socioeconomic status, research led by scientists at Johns Hopkins and the National Institute on Aging shows. Conducted in a racially and socioeconomically diverse sample of participants from the city of Baltimore, Md., the study could help researchers eventually develop strategies to prevent CKD in vulnerable populations.
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc., today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.
› Verified 1 days ago
Damian Joseph Collins, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1700 Spring Hill Ave, Suite 100, Mobile, AL 36604 Phone: 251-435-1200 Fax: 251-435-6357 | |
Lenore Landers Pierce, MD Nephrology Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-639-5775 Fax: 251-631-3581 | |
Peter Chestnutt Coats, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 6701 Airport Blvd, Suite A-101, Mobile, AL 36608 Phone: 251-633-8880 Fax: 251-634-4502 | |
Mr. Stephen Reeves Dill, MD Nephrology Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd # 11n, Mobile, AL 36608 Phone: 251-445-2412 Fax: 850-981-1878 | |
Dr. Dale Scott Kirby Jr., MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D-330, Mobile, AL 36608 Phone: 251-607-9797 Fax: 251-607-9761 | |
Sandeep Vidyadhar Bhadkamkar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-266-3580 Fax: 251-266-3581 | |
Reynaldo Rodriguez, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3601 Springhill Business Park, Mobile, AL 36608 Phone: 251-873-6192 Fax: 251-873-6193 |